FDA Approves Shorter Infusion Time for MS Drug Ocrelizumab ...Middle East

Medscape - News
The FDA okayed an infusion time of 2 hours for MS patients. The approval was based on a study that shows that safety is comparable to the conventional 3.5-hour infusion regimen. FDA Approvals

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves Shorter Infusion Time for MS Drug Ocrelizumab )

Apple Storegoogle play

Also on site :

Most viewed in News


Latest News